Press Releases

Biobot Analytics Named to TIME100 Most Influential Companies List

March 30, 2022

March 30, 2022 – Biobot Analytics was named to the second annual TIME100 Most Influential Companies list, which recognizes 100 companies making an extraordinary impact around the world. Biobot was selected for its pioneering wastewater epidemiology work that has helped countless public health officials better track and stay on top of COVID-19 outbreaks. 

“We’re very honored to be recognized by TIME as one of the most influential companies for 2022,” said Mariana Matus, Biobot CEO. “Biobot’s mission has always been to make a positive impact in the field of public health, and we’re incredibly proud to be listed alongside so many innovative companies from all over the world.” 

To assemble the list, TIME solicited nominations from every sector—ranging from health care and entertainment to transportation and technology—from their editors and correspondents around the world, as well as from industry experts. Then, TIME editors evaluated each candidate on key factors, including relevance, impact, innovation, leadership and success.

See the full list: time.com/100companies 

Read TIME’s feature: time.com/collection/time100-companies-2022/6159393/biobot-analytics 


About Biobot Analytics 

Biobot Analytics is a global leader in wastewater epidemiology, founded with the goal of transforming wastewater infrastructure into real-time public health observatories. Having worked at more than 700 locations across all 50 US states and several countries, Biobot produces actionable information from wastewater to improve the health of communities around the world. Biobot’s pioneering data platform also supports building-level monitoring for enterprise customers and minimizes business operation disruptions for seamless return-to-office plans.

Learn more about our Government and Enterprise platforms at our website, www.biobot.io/government & www.biobot.io/enterprise.More information on our mission and technology is available at our website, www.biobot.io.